Literature DB >> 9220169

Search for cytomegalovirus-specific immunoglobulin M: comparison between a new western blot, conventional western blot, and nine commercially available assays.

T Lazzarotto1, S Brojanac, G T Maine, M P Landini.   

Abstract

We tested 101 serum samples obtained from pregnant women for the presence of human cytomegalovirus (HCMV)-specific IgM with nine different commercially available kits and with two Western blotting (WB) tests previously developed in our laboratory. The conventional WB test contains viral structural proteins separated on a gel from purified HCMV particles and transferred to nitrocellulose. The new WB test contains viral structural proteins and three recombinant proteins which contain the significant immunogenic portions of pp150 (ppUL32), pp52 (ppUL44), and p130 (pUL57). The results obtained indicate that the new WB test combines high specificity (92.5%) with high sensitivity (95.0%), characteristics that, in combination, have not been obtained with any of the other tests.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220169      PMCID: PMC170555          DOI: 10.1128/cdli.4.4.483-486.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  20 in total

1.  Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting.

Authors:  T Lazzarotto; B Dalla Casa; B Campisi; M P Landini
Journal:  J Clin Lab Anal       Date:  1992       Impact factor: 2.352

2.  Immunoblot analysis of the humoral immune response in primary cytomegalovirus infection.

Authors:  D Gold; R Ashley; H H Handsfield; M Verdon; L Leach; J Mills; L Drew; L Corey
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

3.  A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.

Authors:  T Lazzarotto; G T Maine; P Dal Monte; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus.

Authors:  M P Landini; A Ripalti
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

5.  An enzyme labelled nuclear antigen immunoassay for detection of cytomegalovirus IgM antibodies in human serum: specific and non-specific reactions.

Authors:  C M Nielsen; K Hansen; H M Andersen; J Gerstoft; B F Vestergaard
Journal:  J Med Virol       Date:  1987-05       Impact factor: 2.327

6.  Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants.

Authors:  S Stagno; M K Tinker; C Elrod; D A Fuccillo; G Cloud; A J O'Beirne
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

7.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

8.  Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.

Authors:  J Basson; J C Tardy; M Aymard
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Antibodies to human cytomegalovirus structural polypeptides during primary infection.

Authors:  M P Landini; E Rossier; H Schmitz
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

10.  Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes.

Authors:  W van der Bij; R Torensma; W J van Son; J Anema; J Schirm; A M Tegzess; T H The
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

View more
  12 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.

Authors:  G T Maine; R Stricker; M Schuler; J Spesard; S Brojanac; B Iriarte; K Herwig; T Gramins; B Combs; J Wise; H Simmons; T Gram; J Lonze; D Ruzicki; B Byrne; J D Clifton; L E Chovan; D Wachta; C Holas; D Wang; T Wilson; S Tomazic-Allen; M A Clements; G L Wright; T Lazzarotto; A Ripalti; M P Landini
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

4.  An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6.

Authors:  S LaCroix; J A Stewart; M E Thouless; J B Black
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

5.  Prevention of maternal cytomegalovirus infection: current status and future prospects.

Authors:  Jessica L Nyholm; Mark R Schleiss
Journal:  Int J Womens Health       Date:  2010-08-09

Review 6.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Authors:  T Lazzarotto; A Ripalti; G Bergamini; M C Battista; P Spezzacatena; F Campanini; P Pradelli; S Varani; L Gabrielli; G T Maine; M P Landini
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform.

Authors:  M G Revello; C Vauloup-Fellous; L Grangeot-Keros; J van Helden; Y Dickstein; I Lipkin; A Mühlbacher; T Lazzarotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-01       Impact factor: 3.267

9.  Prevalence of congenital cytomegalovirus infection in symptomatic newborns under 3 weeks in Tehran, Iran.

Authors:  Mina Ebrahimi-Rad; Talayeh Seyed Shakeri; Fariba Shirvani; Kiana Shahrokhi; Nader Shahrokhi
Journal:  BMC Infect Dis       Date:  2017-10-18       Impact factor: 3.090

10.  Diagnosis of congenital cytomegalovirus infection in high risk neonates.

Authors:  Ehab Abd Elmoniem Albanna; Randa Saddek Abd El-Latif; Hend Alsayed Sharaf; Maha Kamal Gohar; Basem Mohamed Ibrahim
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-10       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.